ApicHope Pharmaceutical Co., Ltd

SZSE:300723 Stock Report

Market Cap: CN¥7.4b

ApicHope Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Hanxiong Li

Chief executive officer

CN¥653.6k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership16.1%
Management average tenureno data
Board average tenureless than a year

Recent management updates

Recent updates

Revenues Not Telling The Story For ApicHope Pharmaceutical Co., Ltd (SZSE:300723) After Shares Rise 38%

Oct 09
Revenues Not Telling The Story For ApicHope Pharmaceutical Co., Ltd (SZSE:300723) After Shares Rise 38%

Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?

Jun 27
Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?

ApicHope Pharmaceutical (SZSE:300723) Is Paying Out A Larger Dividend Than Last Year

May 27
ApicHope Pharmaceutical (SZSE:300723) Is Paying Out A Larger Dividend Than Last Year

ApicHope Pharmaceutical's (SZSE:300723) Shareholders Have More To Worry About Than Only Soft Earnings

May 03
ApicHope Pharmaceutical's (SZSE:300723) Shareholders Have More To Worry About Than Only Soft Earnings

Bearish: Analysts Just Cut Their ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Revenue and EPS estimates

May 02
Bearish: Analysts Just Cut Their ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Revenue and EPS estimates

ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet

Mar 15
ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet

Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings

Feb 27
Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings

CEO

Hanxiong Li (50 yo)

no data

Tenure

CN¥653,600

Compensation

Mr. Hanxiong Li serves as Chairman of the Board of Directors and General Manager at ApicHope Pharmaceutical Co., Ltd (formerly Yipinhong Pharmaceutical Co., Ltd). He is Director of Arthrosi Therapeutics, I...

Board Members

NamePositionTenureCompensationOwnership
Hanxiong Li
Chairman of the Board of Directors & GMno dataCN¥653.60k16.06%
CN¥ 1.2b
Dongling Yang
Deputy GM & Non-Independent Directorno dataCN¥1.32mno data
Kejian Zhang
Independent Directorless than a yearno datano data
Zhihong Yan
Non-Employee Supervisorless than a yearCN¥1.01mno data
Handong Li
Non-Independent Directorno dataCN¥453.60k3.04%
CN¥ 224.6m
Liangwen Huang
Chairman of the Supervisory Boardno datano datano data
Ruiyu Ke
Supervisor2.9yrsno datano data
Yingying Zhang
Non-Employee Supervisorno datano datano data
Jianhong Tao
Independent Director2.9yrsCN¥120.00kno data
Deming Yang
Independent Director2.9yrsCN¥120.00k0.0044%
CN¥ 329.1k
Qiwu Xie
Non-Employee Supervisorless than a yearno datano data
Xianhua Hu
Independent Directorless than a yearno datano data

0.3yrs

Average Tenure

50yo

Average Age

Experienced Board: 300723's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.